MarketResearch.biz delivers in-depth insights on the global genome engineering market in its upcoming report titled, “Global Genome Engineering Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global genome engineering market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global genome engineering market report has been segmented on the basis of technology, application, end user, and region.
Genome editing is a technique that makes specific changes in DNA of a cell or organisms. It is used to precisely and efficiently modify DNA with a cell. Genome editing involves making cut at specific DNA sequences with the help of enzymes called engineered nucleases. Furthermore, genome editing can be used to remove, add, or alter DNA in the genome and it is widely used for research and treatment purpose. The treatment conditions include AIDS, leukemia, various infectious and genetic disorders. Genome engineering is also known as gene editing.
Advancements in gene editing technologies and increasing number of collaboration among manufacturing companies and research institutions for development of advance technologies are major factor expected to drive the growth of global genome engineering market over the forecast period. Furthermore, increasing government funding in the number of genomics projects to solve the various food, healthcare and environmental issues is expected to fuel the market growth. Increasing prevalence of infectious diseases and cancer globally is another factor expected to drive the growth of global genome engineering market over the forecast period.
However, ethical challenges associated with gene therapy and stringent regulations for approval of the product is expected to limit the market growth over the forecast period.
North America market dominates the global genome engineering market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the presence of well-developed healthcare infrastructure, presence of large number of manufacturers, and availability of skilled professionals in the region. Europe accounts for second-largest revenue share contribution to the global genome engineering market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to the improving healthcare infrastructure, increasing number of research institutes and government funding’s in the region.
Global Genome Engineering Market Segmentation:
Global genome engineering market segmentation, by technology:
- TALEN (Transcription activator like effector nucleases)
- Zinc Finger Nuclease
- Others (Anti-sense and Recombinant Adeno-Associated Virus)
Global genome engineering market segmentation, by application:
- Cell Line Engineering
- Genetic Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
Global genome engineering market segmentation, by end user:
- Pharmaceutical and Biotechnological Companies
- Research and Academic Institutions
- Clinical Research Organizations
Global genome engineering s market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Thermo Fisher Scientific
- New England Biolabs
- OriGene Technologies, Inc.
- bluebird bio, Inc.
- Takara Bio USA, Inc.
- Cellectis S.A.
- Precision Biosciences, Inc.
- Sangamo Therapeutics, Inc.
- Merck KGaA
- Lonza Group Ltd.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!